WHAT THIS STUDY ADDS
Current evidence does not indicate that neuraminidase inhibitor exposure
during pregnancy is not associated with increased risks of overall
congenital malformations in offspring.
Furthermore analysis did not indicate increased risks of other adverse
neonatal outcomes in offspring exposed to neuraminidase inhibitors.
This study supports the current guidelines stating that oseltamivir is
recommended for influenza treatment during pregnancy.